Search

Your search keyword '"Moulis G"' showing total 680 results
Start Over Author "Moulis G"
680 results on '"Moulis G"'

1. Validation of Discharge Diagnosis of Sickle Cell Disease Vaso-Occlusive Episodes in the French Hospital Electronic Database

Author

Walter O, Maquet J, Derumeaux H, Moulis G, and Lafaurie M

Subjects
sickle cell anemia, vaso occlusive crisis, predictive value of test, epidemiology, Infectious and parasitic diseases, RC109-216
Abstract

Ondine Walter,1,2 Julien Maquet,1,2 Helene Derumeaux,3 Guillaume Moulis,1,2 Margaux Lafaurie2,4 1Service de Médecine Interne, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; 2Centre d’Investigation Clinique 1436, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; 3Département d’Information Médicale, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; 4Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Centre Hospitalier Universitaire de Toulouse, Toulouse, FranceCorrespondence: Ondine WalterService de Médecine Interne, pavillon URM, CHU Purpan, place du Dr Baylac, TSA 40031, 31059, Toulouse Cedex 9, FranceTel +33 561 779 677Fax +33 561 778 058Email walter.o@chu-toulouse.frKeywords: sickle cell anemia, vaso occlusive crisis, predictive value of test, epidemiology

Published
2021

2. Assessment of the Accuracy of Using ICD-10 Codes to Identify Systemic Sclerosis

Author

De Almeida Chaves S, Derumeaux H, Do Minh P, Lapeyre-Mestre M, Moulis G, and Pugnet G

Subjects
systemic sclerosis international classification of diseases positive predictive value sensitivity hospital database, Infectious and parasitic diseases, RC109-216
Abstract

Sébastien De Almeida Chaves,1 Hélène Derumeaux,2 Phuong Do Minh,1 Maryse Lapeyre-Mestre,3– 5 Guillaume Moulis,1,4,5 Grégory Pugnet1,4,5 1Department of Internal Medicine, CHU Toulouse, Toulouse, France; 2Department of Medical Information, CHU Toulouse, Toulouse, France; 3Department of Medical and Clinical Pharmacology, CHU Toulouse, Toulouse, France; 4UMR 1027 Inserm-University of Toulouse, Toulouse, France; 5Clinical Investigation Center 1436, CHU Toulouse, Toulouse, FranceCorrespondence: Grégory PugnetService de Médecine Interne, CHU Toulouse Purpan, 1 Place du Dr Joseph Baylac, TSA 40031, 31059, Toulouse Cedex 9, FranceTel +33 5 61 77 71 26Fax +33 5 61 77 71 24Email pugnet.g@chu-toulouse.frImportance: With the increased use of data from electronic medical records for research, it is important to validate in-patient electronic health records/hospital electronic health records for specific diseases identification using International Classification of Diseases, Tenth Revision (ICD-10) codes.Objective: To assess the accuracy of using ICD-10 codes to identify systemic sclerosis (SSc) in the French hospital database.Design, Setting, and Participants: Electronic health record database analysis. The setting of the study’s in-patient database was the Toulouse University Hospital, a tertiary referral center (2880 beds) that serves approximately 2.9 million inhabitants. Participants were patients with ICD-10 discharge diagnosis codes of SSc seen at Toulouse University Hospital between January 1, 2010, and December 31, 2017.Main Outcomes and Measures: The main outcome was the positive predictive value (PPV) of discharge diagnosis codes for identifying SSc. The PPVs were calculated by determining the ratio of the confirmed cases found by medical record review to the total number of cases identified by ICD-10 code.Results: Of the 2766 hospital stays, 216 patients were identified by an SSc discharge diagnosis code. Two hundred were confirmed as SSc after medical record review. The overall PPV was 93% (95% CI, 88– 95%). The PPV for limited cutaneous SSc was 95% (95% CI, 85– 98%).Conclusions and Relevance: Our results suggest that using ICD-10 codes alone to capture SSc is reliable in The French hospital database.Keywords: systemic sclerosis, International Classification of Diseases, positive predictive value, sensitivity, hospital database

Published
2020

3. Platelet Count within the Normal Range at Hospital Admission is Associated with Mortality in Patients with Community-Acquired Pneumonia

Author

Moulis G, Christiansen CF, Darvalics B, Andersen IT, and Nørgaard M

Subjects
platelet count, thrombocytopenia, thrombocytosis, community-acquired pneumonia, mortality., Infectious and parasitic diseases, RC109-216
Abstract

Guillaume Moulis, Christian Fynbo Christiansen, Bianka Darvalics, Ina Trolle Andersen, Mette Nørgaard Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, DenmarkCorrespondence: Guillaume MoulisDepartment of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Olof Palmes Allé 43-45, Aarhus N 8200, DenmarkTel +45 871 68205Fax +45 871 67215Email gmoulis@hotmail.comBackground: Apart from their hemostatic role, platelets are immune cells that play a role in fighting infections. The presence of thrombocytopenia and thrombocytosis at hospital admission are predictors of mortality in community-acquired pneumonia patients. We hypothesized that variations in platelet counts within the normal range also may be associated with mortality in these patients.Methods: The study included all adults in the North and Central Denmark Regions with a first acute hospital admission for community-acquired pneumonia during 2006– 2012. We assessed the association between the first platelet count within ± 24 hours of admission (within the normal range of 150 to 400 x 109/L) and 30-day mortality using Cox models. Analyses were adjusted for age, sex, Charlson Comorbidity Index score, hemoglobin level, leukocyte count, and creatinine level at admission.Results: Among the 12,905 study patients, 30-day mortality was 12.4%. The mean platelet count upon admission was 250 × 109/L. Compared with the 250– 275 × 109/L category, platelet counts of 151– 175 were associated with a lower 30-day mortality (adjusted hazard ratio [aHR]: 0.79, 95% confidence interval [CI]: 0.63– 0.99), while higher platelet counts were associated with a higher 30-day mortality (351– 375 × 109/L, aHR: 1.34, 95% CI: 1.07– 1.68; 376– 400× 109/L, aHR: 1.21, 95% CI: 0.94– 1.56).Conclusion: Platelet counts, even within the normal range, are associated with mortality in adult patients hospitalized for community-acquired pneumonia.Keywords: platelet count, thrombocytopenia, thrombocytosis, community-acquired pneumonia, mortality

Published
2020

4. Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus

Author

Moulis G, Ibañez B, Palmaro A, Aizpuru F, Millan E, Lapeyre-Mestre M, Sailler L, and Cambra K

Subjects
epidemiology, pharmacoepidemiology, electronic healthcare database, cross-national study, population-based study, type 2 diabetes mellitus., Infectious and parasitic diseases, RC109-216
Abstract

Guillaume Moulis,1–3,* Berta Ibañez,4–6,* Aurore Palmaro,2,3 Felipe Aizpuru,6–8 Eduardo Millan,6,8 Maryse Lapeyre-Mestre,2,3,9 Laurent Sailler,1–3 Koldo Cambra5,6,10 1Department of Internal Medicine, Toulouse University Hospital, Toulouse, France; 2UMR1027 INSERM, University of Toulouse, Toulouse, France; 3Clinical Investigation Center 1436, Toulouse University Hospital, Toulouse, France; 4Navarrabiomed, Health Department, Public University of Navarra, Pamplona, Spain; 5IdiSNA, Pamplona, Spain; 6Health Service Research on Chronic Patients Network (REDISSEC), Pamplona, Spain; 7Research Unit Araba (BioAraba), Osakidetza-Basque Health Department, Vitoria-Gasteiz, Spain; 8Healthcare Services Sub-directorate, Osakidetza-Basque Health Service, Araba, Spain; 9Department of Medical and Clinical Pharmacology, Toulouse University Hospital, Toulouse, France; 10Institute of Public Health and Labour Health of Navarra, Pamplona, Spain *These authors contributed equally to this work Aim: The EPICHRONIC (EPIdemiology of CHRONIC diseases) project investigated the possibility of developing common procedures for French and Spanish electronic health care databases to enable large-scale pharmacoepidemiological studies on chronic diseases. A feasibility study assessed the prevalence of type 2 diabetes mellitus (T2DM) in Navarre and the Basque Country (Spain) and the Midi-Pyrénées region (France). Patients and methods: We described and compared database structures and the availability of hospital, outpatient, and drug-dispensing data from 5.9 million inhabitants. Due to differences in database structures and recorded data, we could not develop a common procedure to estimate T2DM prevalence, but identified an algorithm specific to each database. Patients were identified using primary care diagnosis codes previously validated in Spanish databases and a combination of primary care diagnosis codes, hospital diagnosis codes, and data on exposure to oral antidiabetic drugs from the French database. Results: Spanish and French databases (the latter termed Système National d’Information Inter-Régimes de l’Assurance Maladie [SNIIRAM]) included demographic, primary care diagnoses, hospital diagnoses, and outpatient drug-dispensing data. Diagnoses were encoded using the International Classification of Primary Care (version 2) and the International Classification of Diseases, version 9 and version 10 (ICD-9 and ICD-10) in the Spanish databases, whereas the SNIIRAM contained ICD-10 codes. All data were anonymized before transferring to researchers. T2DM prevalence in the population over 20 years was estimated to be 6.6–7.0% in the Spanish regions and 6.3% in the Midi-Pyrénées region with ~2% higher estimates for males in the three regions. Conclusion: Tailored procedures can be designed to estimate the prevalence of T2DM in population-based studies from Spanish and French electronic health care records. Keywords: epidemiology, pharmacoepidemiology, electronic health care database, cross-national study, population-based study, type 2 diabetes mellitus

Published
2018

5. Exposition, efficacité et sécurité en vie réelle du romiplostim en France. Données du registre CARMEN-France

Author

Moulis, G., primary, Mahevas, M., additional, Viallard, J.F., additional, Cheze, S., additional, Comont, T., additional, Audia, S., additional, Ebbo, M., additional, Carreiro, M., additional, Madaule, S., additional, Khatibi, S., additional, Dingremont, C., additional, Terriou, L., additional, Balardy, L., additional, Hadj-Khelifa, S., additional, Ruivard, M., additional, Reynaud, Q., additional, Rueter, M., additional, Michel, M., additional, Lapeyre-Mestre, M., additional, Godeau, B., additional, and Bonnotte, B., additional

Published
2024
Full Text
View/download PDF

6. Les hyperéosinophilies et syndromes hyperéosinophiliques : caractéristiques des 550 premiers patients inclus dans la cohorte COHESion, une cohorte nationale multicentrique

Author

Lefèvre, G., primary, Bleuse, S., additional, Ledoult, E., additional, Panel, K., additional, Abou Chahla, W., additional, Elenga Koanga, J.D., additional, Schwarb, L., additional, Outh, R., additional, Terriou, L., additional, Dion, J., additional, Dossier, A., additional, Moulis, G., additional, Abisror, N., additional, Limal, N., additional, Baudet, A., additional, Slama, B., additional, Lioger, B., additional, Viallard, J.F., additional, Machelart, I., additional, Trefond, L., additional, Lifermann, F., additional, Bonnotte, B., additional, Néel, A., additional, Puyade, M., additional, Schleinitz, N., additional, Queyrel, V., additional, Mohr, C., additional, Groh, M., additional, and Kahn, J.E., additional

Published
2024
Full Text
View/download PDF

7. Incidence, description et prise en charge des thromboses veineuses chez les patients adultes atteints de purpura thrombopénique immunologique. Résultats du registre prospectif multicentrique CARMEN-France

Author

Therme, F., primary, Viallard, J.F., additional, Manuela, R., additional, Comont, T., additional, Cheze, S., additional, Audia, S., additional, Ebbo, M., additional, Mahevas, M., additional, Louis, T., additional, Reynaud, Q., additional, Jeandel, P.Y., additional, Moulinet, T., additional, Delphine, G., additional, Guilpain, P., additional, Gouguechon, C., additional, Robbins, A., additional, Ruivard, M., additional, Chabbert, L., additional, Bonnotte, B., additional, Godeau, B., additional, Lapeyre-Mestre, M., additional, Michel, M., additional, Moulis, G., additional, and Carmen, G. Investigateurs, additional

Published
2024
Full Text
View/download PDF

8. Purpura thrombopénique immunologique induit par les médicaments : un coupable peut en cacher un autre…

Author

Juliette, G.C., primary, Bertrand, G., additional, Voisin, S., additional, Zordan, J., additional, Rual, C., additional, Lahmich, M., additional, Lacasia, J. Idoate, additional, Francillette, E., additional, Chaves, S. De Almeida, additional, Maquet, J., additional, Walter, O., additional, Piel-Julian, M.L., additional, Sailler, L., additional, and Moulis, G., additional

Published
2024
Full Text
View/download PDF

10. Taux de rémissions prolongées à l’arrêt d’un traitement par agoniste du récepteur de la thrombopoïétine au cours de la thrombopénie immunologique : suivi à long-terme de l’étude STOPAGO, cohorte prospective multicentrique

Author

Cottu, A., primary, Guillet, S., additional, Viallard, J.F., additional, Riviere, E., additional, Cheze, S., additional, Gobert, D., additional, Néel, A., additional, Graveleau, J., additional, Marolleau, J.P., additional, Lefrere, F., additional, Moulis, G., additional, Lega, J.C., additional, Moignet-Autrel, A., additional, Robbins, A., additional, Crickx, E., additional, Boutin, E., additional, Noël, N., additional, Malphettes, M., additional, Galicier, L., additional, Audia, S., additional, Bonnotte, B., additional, Lambotte, O., additional, Fain, O., additional, Gerfaud-Valentin, M., additional, Terriou, L., additional, Martis, N., additional, Morin, A.S., additional, Perlat, A., additional, Puyade, M., additional, Comont, T., additional, Limal, N., additional, Languille, L., additional, Michel, M., additional, Godeau, B., additional, and Mahevas, M., additional

Published
2024
Full Text
View/download PDF

13. Mortalité : comparaison, causes et déterminants dans les sous-groupes de myopathies inflammatoires idiopathiques suivies dans la cohorte MIIRTALITY

Author

Larrauffie, A., primary, Bost, C., additional, Faruch-Bilfeld, M., additional, Uro-Coste, E., additional, Prevot, G., additional, Piel-Julian, M.L., additional, Cougoul, P., additional, Zordan, J., additional, Barrier, C., additional, Mourguet, M., additional, De Almeida Chaves, S., additional, Maquet, J., additional, Guille, M., additional, Sailler, L., additional, Moulis, G., additional, Alric, L., additional, and Pugnet, G., additional

Published
2024
Full Text
View/download PDF

15. Anémies hémolytiques auto-immunes à anticorps chauds associées aux syndromes myélodysplasiques et aux leucémies myélomonocytaires chroniques

Author

Colbert, J., primary, Moulis, G., additional, Zhao, L.P., additional, Hadjadj, J., additional, Gobert, D., additional, Dion, J., additional, Le Clech, L., additional, Bigot, A., additional, Gaudin, C., additional, Laribi, K., additional, Grobost, V., additional, Nimubona, S., additional, Godmer, P., additional, Comont, T., additional, Thépot, S., additional, Tavernier, E., additional, Mear, J.B., additional, Trouillier, S., additional, Prat, L., additional, Hirsch, P., additional, Fenaux, P., additional, Michel, M., additional, Fain, O., additional, Mekinian, A., additional, and Jachiet, V., additional

Published
2024
Full Text
View/download PDF

16. Utilisation en vie réelle du fostamatinib dans le purpura thrombopénique immunologique. Résultats intermédiaires du registre français

Author

Moulis, G., primary, Mahevas, M., additional, Viallard, J.F., additional, Terriou, L., additional, Cheze, S., additional, Audia, S., additional, Moulinet, T., additional, Ebbo, M., additional, Robbins, A., additional, Comont, T., additional, Carreiro, M., additional, Gil, H., additional, Dingremont, C., additional, Gobert, D., additional, Saunier, A., additional, Gouguechon, C., additional, Guilpain, P., additional, Ruivard, M., additional, Dossier, A., additional, Rueter, M., additional, Chabbert, L., additional, Lapeyre-Mestre, M., additional, Michel, M., additional, Bonnotte, B., additional, and Godeau, B., additional

Published
2024
Full Text
View/download PDF

17. Intravenous immunoglobulin as a rescue therapy for severe adult autoimmune hemolytic anemia: Results from a French multicenter observational study

Author

Michel, M., primary, Saïr, M., additional, Rivière, E., additional, Moulis, G., additional, Comont, T., additional, Costedoat‐Chalumeau, N., additional, Pouchelon, C., additional, Boutboul, D., additional, Benyamine, A., additional, Bert, A., additional, Jeandel, P. ‐Y., additional, Hamrouni, S., additional, Belfeki, N., additional, Lobbes, H., additional, Dossier, A., additional, Gobert, D., additional, Mahevas, M., additional, Godeau, B., additional, Gallien, Y., additional, and Ebbo, M., additional

Published
2024
Full Text
View/download PDF

21. Efficacité et sécurité de la dapsone dans le purpura thrombopénique immunologique. Résultats d’un essai multicentrique randomisé, contrôle par placebo et d’un essai émulé mono bras dans le registre Carmen

Author

Larue, M., primary, Moulis, G., additional, Rueter, M., additional, Audia, S., additional, Terriou, L., additional, Viallard, J.F., additional, Pan-Petesch, B., additional, Royer, B., additional, Bonnotte, B., additional, Galicier, L., additional, Lambotte, O., additional, Lefrere, F., additional, Cheze, S., additional, Ebbo, M., additional, Mahevas, M., additional, Godeau, B., additional, and Michel, M., additional

Published
2023
Full Text
View/download PDF

22. Cytopénies auto-immunes associées aux hémopathies lymphoïdes B indolentes : une étude de cohorte multicentrique française

Author

Zadro, Y., primary, Lusque, A., additional, Graveleau, J., additional, Lemarié, F., additional, Orvain, C., additional, Domnariu, P.A., additional, Gourguechon, C., additional, Crickx, E., additional, Laribi, K., additional, Gobert, D., additional, Adjoumani, L., additional, Berthoux, E., additional, Deroux, A., additional, Durel, M., additional, Ebbo, M., additional, Farhi, J., additional, Humbert, S., additional, Jachiet, V., additional, Cougoul, P., additional, Dion, J., additional, Castel, B., additional, Begey, C., additional, Rieu, J.B., additional, Deshayes, S., additional, Devaux, M., additional, Durieu, I., additional, Nihal, M., additional, Paillassa, J., additional, Lavigne, C., additional, Moulis, G., additional, Mekinian, A., additional, Ysebaert, L., additional, Michel, M., additional, Godeau, B., additional, and Comont, T., additional

Published
2023
Full Text
View/download PDF

23. Efficacité et sécurité du traitement par agonistes du récepteur de la thrombopoïetine dans le purpura thrombopénique immunologique associé à des marqueurs lupiques et la présence d’antiphospholipides : étude multicentrique rétrospective sur 54 patients

Author

Marques, C., primary, Moulis, G., additional, Rousotte, M., additional, Lobbes, H., additional, Bonnotte, B., additional, Viallard, J.F., additional, Costedoat-Chalumeau, N., additional, Deroux, A., additional, Martis, N., additional, Gobert, D., additional, Graveleau, J., additional, Puyade, M., additional, Gilardin, L., additional, Mahevas, M., additional, Michel, M., additional, Sève, P., additional, and Godeau, B., additional

Published
2023
Full Text
View/download PDF

24. Une forme rare d’épanchement péricardique

Author

Zadro, Y., primary, Grünenwald, E., additional, Doazan, J.P., additional, Walter, O., additional, De Almeida Chaves, S., additional, Maquet, J., additional, Piel-Julian, M.L., additional, Moulis, G., additional, and Sailler, L., additional

Published
2023
Full Text
View/download PDF

25. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults

Author

Piel‐Julian, M.‐L., Mahévas, M., Germain, J., Languille, L., Comont, T., Lapeyre‐Mestre, M., Payrastre, B., Beyne‐Rauzy, O., Michel, M., Godeau, B., Adoue, D., Moulis, G., Alric, L., Arista, S., Astudillo, L., Balardy, L., Betrian, S., Bonnet, D., Borel, C., Brechemier, D., Brun, N., Carreiro, M., Castel, B., Caudrelier, L., Cougoul, P., Danu, A., Delavigne, K., Dingremont, C., Faurie, T., Gaches, F., Gaspard, M.‐H., Gaudin, C., Godel‐Labouret, A., Giraud, P., Hadj‐Khelifa, S., Hebraud, B., Khatibi, S., Leplay, L., Leveneur, Y., Limal, N., Ollier, S., Madaule, S., Marchou, B., Martel, C., Martin‐Blondel, G., Montane De La Roque, P., Michaud, M., Moeglin, J., Nuccio, F., Prudhomme, L., Pugnet, G., Recher, C., Remy, V., Sailler, L., Sire, S., Sommet, A., Tavitian, S., Thiercelin‐Legrand, M.‐F., and Vaillant, W.

Published
2018
Full Text
View/download PDF

26. Silence, ça tourne !

Author

Larrauffie, A., primary, Porcheron, M., additional, Pariente, J., additional, Wolfrum, M., additional, Bureau, C., additional, Zadro, C., additional, Otal, P., additional, Broue, P., additional, Sailler, L., additional, Moulis, G., additional, Maquet, J., additional, and Goulabchand, R., additional

Published
2023
Full Text
View/download PDF

27. Incidence et facteurs de risque d’infection sévère à SARS-CoV-2 chez les patients traités par rituximab pour une cytopénie auto-immune : étude rétrospective multicentrique de 222 patients

Author

Sorin, B., primary, Gaigne, L., additional, Garzaro, M., additional, Roy-Peaud, F., additional, Jeandel, P.Y., additional, Mageau, A., additional, Crickx, E., additional, Dossier, A., additional, Delphine, G., additional, Hadjadj, J., additional, Moulis, G., additional, Rasmussen, C., additional, Terrier, B., additional, Ebbo, M., additional, Bonnotte, B., additional, Galicier, L., additional, Michel, M., additional, Mahevas, M., additional, Viallard, J.F., additional, and Godeau, B., additional

Published
2023
Full Text
View/download PDF

29. French practical guidelines for the diagnosis and management of relapsing polychondritis

Author

Arnaud, L., primary, Costedoat-Chalumeau, N., additional, Mathian, A., additional, Sailler, L., additional, Belot, A., additional, Dion, J., additional, Morel, N., additional, Moulis, G., additional, Bader-Meunier, B., additional, Bodaghi, B., additional, Bura Riviere, A., additional, Casadevall, M., additional, Fain, O., additional, Frances, C., additional, Hachulla, E., additional, Hamidou, M., additional, Karakoglou, C., additional, Lambert, M., additional, Lerebours, F., additional, Leroux, G., additional, Mariette, X., additional, Marquette, C.H., additional, Martin, T., additional, Mekinian, A., additional, Papo, T., additional, Piette, J.-C., additional, Puechal, X., additional, Richez, C., additional, Saraux, A., additional, Seve, P., additional, Tankere, F., additional, Terriou, L., additional, and Varin, P., additional

Published
2023
Full Text
View/download PDF

32. Purpura thrombopénique immunologique primaire multiréfractaire de l’adulte : prévalence et complications. Résultats du registre CARMEN-France

Author

Moulis, G., primary, Rueter, M., additional, Mahevas, M., additional, Viallard, J.F., additional, comont, T., additional, Cheze, S., additional, Audia, S., additional, Ebbo, M., additional, Terriou, L., additional, Lega, J.C., additional, Jeandel, P.Y., additional, Bonnotte, B., additional, Michel, M., additional, Lapeyre-Mestre, M., additional, and Godeau, B., additional

Published
2022
Full Text
View/download PDF

33. Seuil de numération plaquettaire associé au saignement chez les patients atteints de purpura thrombopénique immunologique traités par antiagrégants plaquettaires. Résultats du registre CARMEN-France

Author

Ollier, N., primary, Piel-Julian, M.L., additional, Mahevas, M., additional, Viallard, J.F., additional, comont, T., additional, Cheze, S., additional, Audia, S., additional, Ebbo, M., additional, Terriou, L., additional, Lega, J.C., additional, Jeandel, P.Y., additional, Bonnotte, B., additional, Michel, M., additional, Lapeyre-Mestre, M., additional, Godeau, B., additional, and Moulis, G., additional

Published
2022
Full Text
View/download PDF

34. Utilisation des immunoglobulines polyvalentes intraveineuses au cours des anémies hémolytiques auto-immunes de l’adulte : série rétrospective multicentrique de 34 cas

Author

Sair, M., primary, Moulis, G., additional, Boutboul, D., additional, Costedoat-Chalumeau, N., additional, Pouchelon, C., additional, comont, T., additional, Benyamine, A., additional, Delphine, G., additional, Grumet, P., additional, Bert, A., additional, Pierre-Yves, J., additional, Lobbes, H., additional, Pestre, V., additional, Roumieu, V., additional, Sire, S., additional, Dossier, A., additional, Riviere, E., additional, Ebbo, M., additional, and Michel, M., additional

Published
2022
Full Text
View/download PDF

35. Diagnostic de l’aortite par la mesure de l’épaisseur maximale de la paroi aortique après 50 ans : impact de la variabilité de la mesure chez 89 patients

Author

Grouteau, G., primary, Lafourcade, F., additional, Fayolle, H., additional, Maupoint, E., additional, Ricard, C., additional, Pugnet, G., additional, Moulis, G., additional, De Almeida Chaves, S., additional, Maquet, J., additional, Toledano, A., additional, Balardy, L., additional, Bura-Rivière, A., additional, Constantin, A., additional, Beyne-rauzy, O., additional, Delobel, P., additional, Alric, L., additional, Hitzel, A., additional, Faruch-Bilfeld, M., additional, and Sailler, L., additional

Published
2022
Full Text
View/download PDF

39. Efficacité et tolérance des biothérapies ciblant l’interleukine-5 pour le traitement des pneumopathies chroniques idiopathiques à éosinophiles réfractaires et/ou récidivantes

Author

Delcros, Q., primary, Camille, T., additional, Alexandre, V., additional, Marie, G., additional, Frachon, I., additional, Kahn, J.-E., additional, Lefèvre, G., additional, Moulis, G., additional, Uzunhan, Y., additional, Cottin, V., additional, and Groh, M., additional

Published
2022
Full Text
View/download PDF

40. Description du risque infectieux chez les patients avec hypogammaglobulinémie acquise dans le cadre d’une maladie auto-immune et initiant ou poursuivant un traitement par rituximab

Author

Boumaza, X., primary, Lafaurie, M., additional, Treiner, E., additional, Walter, O., additional, Pugnet, G., additional, Martin-Blondel, G., additional, Biotti, D., additional, Ciron, J., additional, Moulis, G., additional, Constantin, A., additional, Tauber, M., additional, Renaudineau, Y., additional, Chauveau, D., additional, and Sailler, L., additional

Published
2022
Full Text
View/download PDF

42. Vascularites à IgA survenues dans les suites d’une infection à SARS-CoV-2 et post vaccination contre la COVID 19 : une série de 19 patients

Author

Ramdani, Y., primary, Bettuzzi, T., additional, Bouznad, A., additional, Delaitre, L., additional, Nassarmadji, K., additional, Paul, C., additional, Galempoix, J.M., additional, Liozon, E., additional, Tieu, A., additional, Augusto, J.F., additional, Richard-Colmant, G., additional, Dekmeer, E., additional, Terrier, B., additional, Perard, L., additional, Moulis, G., additional, Lafaurie, M., additional, Pillebout, E., additional, Maillot, F., additional, and Audemard-Verger, A., additional

Published
2022
Full Text
View/download PDF

44. AB0521 PERICARDITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: CHARACTERISTICS, MANAGEMENT, EVOLUTION AND PREDICTIVE FACTORS FOR RELAPSE. A MONOCENTRIC RETROSPECTIVE STUDY.

Author

Lemeu, M., primary, Lairez, O., additional, Faguer, S., additional, Pugnet, G., additional, Moulis, G., additional, Alric, L., additional, Huart, A., additional, Ribes, D., additional, Piel-Julian, M. L., additional, Constantin, A., additional, Chauveau, D., additional, and Sailler, L., additional

Published
2022
Full Text
View/download PDF

45. POS1178 PRESCRIBING RITUXIMAB IN PATIENTS WITH AUTO-IMMUNE DISEASES AND ACQUIRED HYPOGAMMAGLOBULINEMIA: DESCRIPTION OF THE RISK OF SEVERE INFECTION IN 121 PATIENTS BEFORE THE SARS-Cov2 ERA

Author

Xavier, B., primary, Lafaurie, M., additional, Treiner, E., additional, Walter, O., additional, Pugnet, G., additional, Martin-Blondel, G., additional, Biotti, D., additional, Ciron, J., additional, Moulis, G., additional, Constantin, A., additional, Renaudineau, Y., additional, Chauveau, D., additional, and Sailler, L., additional

Published
2022
Full Text
View/download PDF

50. Une série rétrospective multicentrique évaluant les caractéristiques, la prise en charge et l’évolution des thrombopénies amégacaryocytaires acquises

Author

Roeser, A., primary, Moulis, G., additional, Ebbo, M., additional, Terriou, L., additional, Poullot, E., additional, Lioger, B., additional, Chilles, M., additional, Labussière-Wallet, H., additional, Mausservey, C., additional, Pha, M., additional, Puyade, M., additional, Cheze, S., additional, Limal, N., additional, Michel, M., additional, Godeau, B., additional, and Mahevas, M., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results